Lindbrook Capital, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$26,000
-50.0%
9,7500.0%0.01%
-41.7%
Q2 2021$52,000
+44.4%
9,750
+80.7%
0.01%
+50.0%
Q1 2021$36,000
-43.8%
5,397
-42.7%
0.01%
-50.0%
Q4 2020$64,000
+33.3%
9,415
+46.8%
0.02%
+23.1%
Q3 2020$48,000
+6.7%
6,415
+50.7%
0.01%0.0%
Q2 2020$45,000
-54.5%
4,256
-62.2%
0.01%
-64.9%
Q1 2020$99,000
+350.0%
11,250
+150.0%
0.04%
+236.4%
Q4 2018$22,0004,5000.01%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders